Immunome, Inc. Other Non-Current Liabilities
Immunome, Inc. (IMNM) had Other Non-Current Liabilities of $1.34 million as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2024-03-28
- 2023-12-31: Other Liabilities, Noncurrent $1.34M.
- 2023-09-30: Other Liabilities, Noncurrent $122.00K.
- 2022-12-31: Other Liabilities, Noncurrent $62.00K.
- 2022-09-30: Other Liabilities, Noncurrent $93.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2023-12-31 | $1.34M 10-K · filed 2024-03-28 |
| 2023-09-30 | $122.00K 10-Q · filed 2023-11-09 |
| 2022-12-31 | $62.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $93.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $124.00K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $147.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $12.00K 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |